Searched for
BHARAT BIOTECH GROUP
Info Edge says it invested Rs 1,003 crore on AI, deeptech startups since 2020Info Edge, the parent of Naukri, has significantly boosted its AI and deeptech investments, pouring Rs 1,003 crore into 54 startups since 2...- Tata Chemicals CEO R Mukundan takes over as CII president for 2026-27R Mukundan, CEO of Tata Chemicals, has assumed the presidency of the Confederation of Indian Industry (CII) for 2026-27, succeeding Rajiv M...
- Bharat Biotech picks up 20 per cent stake in Eastman Exports Global ClothingA press release from Eastman Exports said it will use the new investment for capital expenditure, strengthening backward integration and cu...
- Covaxin to be evaluated as COVID-19 vaccine candidate in US: Bharat BiotechCovaxin has already been granted Emergency Use Listing (EUL) in 13 countries as on January 31 according to the WHO. Covaxin was granted EUL...
- Hester Biosciences to roll out Covaxin drug substance by April 2022Ahmedabad-based Hester Biosciences is a part of Gujarat Covid Vaccine Consortium (GCVC), which in May this year signed an agreement with Bh...
- Covaxin gets WHO nod for emergency use, move to ease travel for those who took made-in-India vaccineCovaxin was also reviewed by WHO's Strategic Advisory Group of Experts on Immunisation (SAGE), which recommended the use of the vaccine in ...
- Covaxin gets WHO approval for emergency use listingWHO's TAG is an independent advisory group that provides recommendations to the WHO on whether a Covid 19 vaccine can be listed for emergen...
- Bharat Biotech's Covaxin gets WHO okay for emergency useHyderabad-based Bharat Biotech, which has developed Covaxin, submitted EOI (Expression of Interest) to the WHO on April 19 for the vaccine'...
- We trust Indian industry, Bharat Biotech has been submitting data regularly, very quickly: WHO official on Covaxin EULBharat Biotech's Covaxin and AstraZeneca and Oxford University's Covishield are the two widely used vaccines in India.
- Technical Advisory Group seeks additional clarification on Covaxin for Emergency Use ListingWhile the WHO has so far approved Covid-19 vaccines of Pfizer-BioNTech, AstraZeneca-SK Bio/Serum Institute of India, Johnson & Johnson-Jans...
- WHO's advisory group set to meet on October 26 to decide on Covaxin EUL approvalWhile the WHO has so far approved Covid-19 vaccines of Pfizer-BioNTech, AstraZeneca-SK Bio/Serum Institute of India, Johnson & Johnson-Jans...
- WHO advisory group to meet on Oct 26 to decide on Bharat Biotech’s CovaxinWHO had earlier said that Bharat Biotech has been submitting data to it on a rolling basis and had submitted additional information on 27 S...
- Bharat Bio hopes to soon submit trial data for intranasal vaccine"The trials are ongoing, and we expect to submit data by the end of this year," a company insider said. The trials, including over 600 part...
- Awaiting regulatory approvals to launch Covaxin for children: Bharat Biotech"This represents one of the first approvals worldwide for COVID-19 vaccines for the 2-18 age group. Bharat Biotech sincerely thanks the DCG...
- COVAXIN: News reports on submitting Phase-3 data to WHO is incorrect, says Bharat BiotechBharat Biotech's pre-submission meeting has been scheduled on June 23 for evaluation of the World Health Organisation (WHO)'s Emergency Use...
- DCGI approves Phase 2, 3 clinical trials of COVAXIN on children aged 2 to 18 years"The National Regulator of the country, the Drugs Controller General of India (DCGI), after careful examination, has accepted the recommend...
- Bharat Biotech plans more vaccine from Bengaluru unitBharat Biotech has written to the department of biotechnology for funds to expand its manufacturing capacities. “The company has asked for ...
- Bharat Biotech seeks govt aid to boost Covid vaccine productionThe company has written to the Department of Biotechnology seeking Rs 100 crore to ramp up its manufacturing capacity.
- Bharat Biotech's corona vaccine Covaxin 81% effectiveThe trials involved 25,800 participants and was conducted in partnership with the Indian government's medical research body.
- Bharat Biotech begins Phase-III trials for COVID-19 vaccine, Covaxin, with 26,000 volunteers"This is India's first phase-III efficacy study for a Covid-19 vaccine, and the largest phase-III efficacy trial ever conducted in India," ...
Load More
